G1 Therapeutics Inc
(GTHX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 324,911 | 347,797 | 369,290 | 390,524 | 188,227 |
| TOTAL | $328,277 | $348,884 | $370,133 | $392,013 | $189,889 |
| Non-Current Assets | |||||
| PPE Net | 1,515 | 1,343 | 1,137 | 1,006 | 711 |
| Other Non-Current Assets | 1,861 | 1,448 | 0 | 0 | 0 |
| TOTAL | $3,376 | $2,791 | $1,137 | $1,006 | $711 |
| Total Assets | $331,653 | $351,675 | $371,270 | $393,019 | $190,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,292 | 3,076 | 3,377 | 2,752 | 3,311 |
| Accrued Expenses | 14,232 | 8,112 | 8,985 | 10,922 | 10,686 |
| Other current liabilities | 369 | 361 | N/A | N/A | N/A |
| TOTAL | $17,893 | $11,549 | $12,362 | $13,674 | $13,997 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,090 | 1,185 | 88 | 90 | 79 |
| TOTAL | $1,090 | $1,185 | $88 | $90 | $79 |
| Total Liabilities | $18,983 | $12,734 | $12,450 | $13,764 | $14,076 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,523 | 37,467 | 37,408 | 37,185 | 33,405 |
| Common Shares | 4 | 4 | 4 | 4 | 3 |
| Retained earnings | -269,048 | -238,358 | -214,406 | -190,315 | -170,397 |
| Other shareholders' equity | -8 | -8 | -8 | -8 | -8 |
| TOTAL | $312,670 | $338,941 | $358,820 | $379,255 | $176,524 |
| Total Liabilities And Equity | $331,653 | $351,675 | $371,270 | $393,019 | $190,600 |